Table 2 Correlation between high expression of lncFTX and clinicopathologic features for tumor
From: Prognostic significance of long non-coding RNA five prime to XIST in various cancers
Clinicopathologic features | Studies | OR/HR and 95% CI | Effects model | Heterogeneity (p; I2) |
|---|---|---|---|---|
Tumor differentiation (PD VS Well/moderate) | 5 | 1.54 0.56–4.21) | Random | 0.000; 85.4% |
TNM stage (III-IV VS I-II) | 9 | 2.30 (1.74–3.03) | Fixed | 0.198; 27.7% |
Vessel invasion (Yes VS No) | 3 | 1.28 (0.80–2.05) | Fixed | 0.951; 0.0% |
Lymph node metastasis (Yes VS No) | 5 | 3.01 (2.00–4.52) | Fixed | 0.634; 0.0% |
Distant metastasis (Yes VS No) | 4 | 3.68 (2.13–6.34) | Fixed | 0.954; 0.0% |
Overall survival | 8 | 1.83 (1.20–2.81) | Random | 0.001; 72.2% |